Form 4: Pharvaris Director Sells Shares Under 10b5-1 Plan

Pharvaris N.V. director Berndt Modig reported the sale of 2,292 shares of common stock for $28.60 per share under a pre-arranged trading plan.

Summary

• Berndt Modig, a Director and Chief Executive Officer of Pharvaris N.V., reported a transaction on April 16, 2026.
• Modig sold 2,292 shares of common stock at a weighted average price of $28.60 per share.
• These sales were conducted under a Rule 10b5-1 trading plan, which is designed to comply with SEC safe harbor provisions.
• Following this transaction, Modig beneficially owns 139,792 shares of common stock directly.
• Additionally, Modig has indirect beneficial ownership of 950,000 shares through Schoodic Management BV, an entity he controls.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While an insider sale can be a negative signal, the execution under a Rule 10b5-1 plan mitigates concerns about immediate negative outlook.

Positives

• The sale was executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially non-insider trading related activity.
• The reporting person continues to hold a significant number of shares directly (139,792) and indirectly (950,000), suggesting continued commitment to the company.

Negatives

• A significant number of shares were sold by a key executive and director.

Risks

• Potential for negative market perception due to a director's stock sale, even if conducted under a 10b5-1 plan.
• The sale of shares could be interpreted as a lack of confidence in future stock performance, although the 10b5-1 plan mitigates this to some extent.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, which solely reports a change in beneficial ownership.

Management Comments

• The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan.
• The sales prices for the transactions ranged from $28.32 to $28.82.
• The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. While sales by executives can sometimes signal concerns, the use of a Rule 10b5-1 plan suggests a pre-determined strategy for managing personal stock holdings, often used to diversify or meet financial obligations without implying negative views on the company's prospects.

Related Party Transactions

• Berndt Modig, as a Director and CEO, is a related party. The sale of shares by Modig is a transaction involving a related party.

Stakeholder Impact

• Shareholders: May view the sale with caution, although the 10b5-1 plan provides some reassurance.
• Employees: May interpret the sale as a signal from leadership, though the plan's nature should be considered.
• Management: The transaction is a standard disclosure for executive stock management.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 plan.
• The company may provide further disclosures if additional insider transactions occur.

Key Dates

Keywords

Pharvaris N.V., PHVS, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Berndt Modig, Beneficial Ownership, SEC Filing